SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Rick Costantino who wrote (1174)11/16/1997 6:02:00 PM
From: Marshall Teitelbaum  Respond to of 2205
 
Rick,

As you said, this is one of the key risks....is there really a reason for tissue engineering, and does it truly work? It appears to be poised nicely if so, but it is still very early on in this area. ATIS appears to be in a similar situation as ISIP in this sense, as the question there is if antisense technology truly works, although early data appears to indicate very much that it does in my opinion.

Hope all is well,

Marshall


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News